Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A concise volatility overview comparing balanced funds and the SP 500 during retirement, with implications for risk management.
24,195 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Roughly 1 in 10 Medicare Advantage enrollees will lose their current plan for 2026 as insurers retreat from markets. ...
Ripple secures a key regulatory foothold in Luxembourg, signaling EU-wide expansion. XRP ETFs continue drawing instit...
GameStop’s walking away from a massive pay package marks a dramatic pivot as the company uses its stock to press a bi...
A renewed push to replenish and expand U.S. missile arsenals is set to lift production and backlog across defense sup...
Microsoft rides a renewed wave of optimism as cloud and AI demand fuels a bullish price target consensus. Analysts in...
The Supreme Court ruling blocks state-law cancer claims against Bayer tied to Roundup, a decision that reshapes litig...
Investors chase the next big moonshot, but headlines can blur reality. This guide breaks down how to assess whether s...
A growing share of college students are parents, with about 3 million juggling classes and childcare. Most don’t grad...
Bloom Energy has sprinted higher this year on an AI-powered energy story. As a late entrant, you’ll want a clear view...
Meet Ornith, the open-source coding model built for agents rather than humans. This article breaks down how it works,...
NVIDIA has surged to the top of many investors' lists as AI demand accelerates. This highest-conviction stock right n...